Related references
Note: Only part of the references are listed.Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
Vera Grossmann et al.
DIABETES CARE (2015)
Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study
Birgit Klueppelholz et al.
DIABETOLOGIA (2015)
Glycated Hemoglobin Levels Are Mostly Dependent on Nonglycemic Parameters in 9398 Finnish Men Without Diabetes
Maria Fizelova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Surrogate measures of insulin resistance: does one size fit all?
Donald C. Simonson
DIABETOLOGIA (2015)
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
Stephen Kaptoge et al.
EUROPEAN HEART JOURNAL (2014)
Depressive disorder, coronary heart disease, and stroke: dose-response and reverse causation effects in the Whitehall II cohort study
Eric J. Brunner et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2014)
Inflammatory Markers and Risk of Type 2 Diabetes A systematic review and meta-analysis
Xia Wang et al.
DIABETES CARE (2013)
Association of Subclinical Inflammation With Polyneuropathy in the Older Population KORA F4 study
Christian Herder et al.
DIABETES CARE (2013)
Anti-inflammatory cytokines and risk of type 2 diabetes
C. Herder et al.
DIABETES OBESITY & METABOLISM (2013)
Association of Lifecourse Socioeconomic Status with Chronic Inflammation and Type 2 Diabetes Risk: The Whitehall II Prospective Cohort Study
Silvia Stringhini et al.
PLOS MEDICINE (2013)
Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study
Kristine Faerch et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Adiponectin, driver or passenger on the road to insulin sensitivity?
Risheng Ye et al.
MOLECULAR METABOLISM (2013)
Adiponectin Trajectories Before Type 2 Diabetes Diagnosis Whitehall II study
Adam G. Tabak et al.
DIABETES CARE (2012)
Prediabetes: a high-risk state for diabetes development
Adam G. Tabak et al.
LANCET (2012)
Adipocytokines, Hepatic and Inflammatory Biomarkers and Incidence of Type 2 Diabetes. The CoLaus Study
Pedro Marques-Vidal et al.
PLOS ONE (2012)
Increased IL-1β activation, the culprit not only for defective insulin secretion but also for insulin resistance?
Marianne Boeni-Schnetzler et al.
CELL RESEARCH (2011)
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
Helga Ellingsgaard et al.
NATURE MEDICINE (2011)
Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes Whitehall II Prospective Cohort Study
Maren Carstensen et al.
DIABETES (2010)
Interleukin-1β May Mediate Insulin Resistance in Liver-Derived Cells in Response to Adipocyte Inflammation
Ori Nov et al.
ENDOCRINOLOGY (2010)
Hypoadiponectinemia-Cause or Consequence of Human Insulin Resistance?
Joshua R. Cook et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Transforming Growth Factor-beta 1 and Incident Type 2 Diabetes Results from the MONICA/KORA case-cohort study, 1984-2002
Christian Herder et al.
DIABETES CARE (2009)
Association of inflammation with worsening HOMA-insulin resistance
K. Park et al.
DIABETOLOGIA (2009)
Adiponectin Levels and Risk of Type 2 Diabetes A Systematic Review and Meta-analysis
Shanshan Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study
Adam G. Tabak et al.
LANCET (2009)
Elevated cystatin C concentration and progression to pre-diabetes
Richard P. Donahue et al.
DIABETES CARE (2007)
Interleukin-1 beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression
Jennifer Jager et al.
ENDOCRINOLOGY (2007)
Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle
H Sell et al.
ENDOCRINOLOGY (2006)
Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002
C Herder et al.
DIABETOLOGIA (2006)
Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose
MA Abdul-Ghani et al.
DIABETES CARE (2006)
Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes -: Results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)
C Herder et al.
DIABETES (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population - The Funagata study
M Daimon et al.
DIABETES CARE (2003)
Inflammatory cytokines and the risk to develop type 2 diabetes -: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
J Spranger et al.
DIABETES (2003)
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
K Maedler et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Validation of the insulin sensitivity index (ISI0,120): comparison with other measures
M Gutt et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2000)
Share Paper
